First Trust Capital Management’s Cartesian Growth Corp II RENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-450,000
Closed -$5.25M 101
2024
Q4
$5.25M Sell
450,000
-1,505,099
-77% -$17.4M 0.4% 57
2024
Q3
$22.4M Buy
1,955,099
+376,867
+24% +$4.29M 1.5% 21
2024
Q2
$17.8M Hold
1,578,232
1.62% 17
2024
Q1
$17.5M Hold
1,578,232
1.49% 15
2023
Q4
$17.3M Buy
1,578,232
+501,750
+47% +$5.46M 1.32% 19
2023
Q3
$11.7M Hold
1,076,482
0.65% 42
2023
Q2
$11.5M Buy
1,076,482
+847,619
+370% +$8.96M 0.68% 51
2023
Q1
$2.4M Buy
228,863
+28,865
+14% +$300K 0.1% 167
2022
Q4
$2.05M Hold
199,998
0.11% 218
2022
Q3
$2.01M Buy
+199,998
New +$2.01M 0.1% 255

Other funds holding RENE

First Trust Capital Management's RENE Position: Q1 2025 in Review

First Trust Capital Management sold out of Cartesian Growth Corp II (RENE) in Q1 2025, closing a stake of 450,000 shares — an estimated $5.25M sold.

First Trust Capital Management first reported a position in RENE in Q3 2022 and held it in 10 quarters. The position peaked at $22.4M in Q3 2024. 17 funds tracked by Wall St. Rank hold RENE as of Q1 2025.

  • First Trust Capital Management reported no remaining Cartesian Growth Corp II position as of Q1 2025 after selling out during the quarter.
  • First Trust Capital Management sold 450,000 Cartesian Growth Corp II shares in Q1 2025, an estimated $5.25M.
  • First Trust Capital Management first reported a position in Cartesian Growth Corp II in Q3 2022 and held it in 10 quarters.
  • First Trust Capital Management's Cartesian Growth Corp II position peaked at $22.4M in Q3 2024.
  • 17 funds tracked by Wall St. Rank held Cartesian Growth Corp II as of Q1 2025.

Based on First Trust Capital Management's 13F filing for Q1 2025, filed 15 May 2025.